What’s on the horizon for nonalcoholic steatohepatitis (NASH) treatment?
The future of NASH treatment is more promising than ever with improved methods for diagnosis and new drugs in development.
Read MoreEvernorth Announces Industry-First Financial Guarantee For GLP-1 Spend
EncircleRx solution now includes financial predictability for health plan sponsors to help expand access for appropriate patients.
Read MoreEvernorth’s New Behavioral Care Practice Offers Quality Care To Improve Mental Well-Being
Evernorth is launching an outpatient behavioral health practice to expand access to quality, in-network therapy for millions of people.
Read MoreWhat impact will the Inflation Reduction Act have on health plans?
Plan sponsors should be aware of the effects the law will have on Medicare Part D over the coming years.
Read MoreExpress Scripts kicks off meetings with independent pharmacists to close gaps in care
A new committee, which includes independent pharmacy owners from across the country, will meet regularly to discuss how Express Scripts can and should work to enable an expanded role for pharmacists.
Read More